Clinical

Dataset Information

0

Cetuximab Monotherapy Maintenance Treatment in mCRC


ABSTRACT: Investigating the efficacy of Cetuximab Monotherapy versus Continuation after induction treatment with chemotherapy + Cetuximab in inoperable or irresectable and non-progressive metastatic colorectal cancer after first line induction treatment for 24 weeks with mFOLFOX6/FOLFIRI and Cetuximab treatment. Reinduction treatment will be done in case of progression.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2230951 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2077756 | ecrin-mdr-crc
| 2228220 | ecrin-mdr-crc
2008-01-31 | GSE5851 | GEO
2008-06-14 | E-GEOD-5851 | biostudies-arrayexpress
| 2329576 | ecrin-mdr-crc
2021-02-26 | PXD015074 | Pride
| PRJNA435545 | ENA
| 2192462 | ecrin-mdr-crc
2017-03-02 | GSE63916 | GEO
2020-03-23 | GSE143279 | GEO